Clinical Trials | October 03, 2023
Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The delegation's visit covered a wide range of topics
Subscribe To Our Newsletter & Stay Updated
